Mitsuya Ito

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Chemopreventive Effects of β‐Carotene, α‐Tocopherol and Five Naturally Occurring Antioxidants on Initiation of Hepatocarcinogenesis by 2‐Amino‐3‐methylimidazo[4,5‐f] qumoline in the Rat

Hiroyuki Tsuda, Nobuaki Uehara, Yoshio Iwahori et al. · Japanese Journal of Cancer Research · 1994 · 109 citations

Medicine, Oncology, Pharmacology +10

Aggressive surgery for liver metastases from gastrointestinal stromal tumors

Yasuo Shima, Tadashi Horimi, T Ishikawa et al. · Journal of Hepato-Biliary-Pancreatic Surgery · 2003 · 49 citations

Medicine, Oncology, Surgery +16

Radiofrequency ablation of early breast cancer followed by delayed surgical resection – A promising alternative to breast-conserving surgery

Shoichiro Ohtani, Mariko Kochi, Mitsuya Ito et al. · The Breast · 2011 · 46 citations · Full text

Medicine, Oncology, Surgery +10

A genetic locus susceptible to the overt proteinuria in BUF/Mna rat

Sin-ichro Murayama, Kyoko Higo, Chunlin Ye et al. · Mammalian Genome · 1998 · 42 citations

Medicine, Genetics, Molecular Genetics +7